Form 8-K - Current report:
SEC Accession No. 0001104659-25-063687
Filing Date
2025-06-27
Accepted
2025-06-27 17:06:07
Documents
14
Period of Report
2025-06-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519021d1_8k.htm   iXBRL 8-K 104267
2 EXHIBIT 99.1 tm2519021d1_ex99-1.htm EX-99.1 13760
3 GRAPHIC tm2519021d1_ex99-1img001.jpg GRAPHIC 3059
  Complete submission text file 0001104659-25-063687.txt   316767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eyen-20250625.xsd EX-101.SCH 3014
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20250625_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20250625_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2519021d1_8k_htm.xml XML 3685
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 251087611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)